Powered by StromaAI™

StromaAI™ is the computational engine that transforms StromaGenesis’s scientific assets into a scalable diagnostic and AI-driven oncology platform.

StromaGenesis’ proprietary artificial intelligence oncology engine, designed to integrate genomic, transcriptomic, and tumor-microenvironment (TME) data into a single computational framework capable of generating high-accuracy diagnostic, prognostic, and therapeutic-guidance insights across multiple cancers.

StromaAI™ serves as the computational core of StromaGenesis. It strengthens, operationalizes, and scales the company’s foundational scientific IP - including:

The proprietary prostate cancer algorithm
CCR5 companion diagnostic markers used to identify therapy-responsive phenotypes
Cav-1 IHC signatures linked to tumor aggressiveness and stromal behavior

By unifying these assets under a single AI-driven architecture, StromaAI™ provides clinicians, CLIA labs, and research partners with a validated, reproducible, and clinically interpretable platform for:

Precision cancer risk prediction
Treatment stratification and therapy decision support
Longitudinal disease monitoring
Multi-cancer algorithmic expansion

StromaAI™ positions StromaGenesis as a computational oncology platform company, transforming decades of biologic discovery into clinically deployable, scalable intelligence, and creating a technology infrastructure capable of supporting diagnostics, therapeutics, and pharma partnerships.